Title for MeetingAbstracts
Alphabetical listing of titles
Dual Therapy with Indinavir/Ritonavir 800/100 mg BID and Efavirenz 600 mg QD Effectively Treats Patients with Combination Nucleoside Analogue Failure: HIV-NAT 009 48-week Analysis.
Dual tropism for lymphocytes and macrophages is a common feature of all HIV isolates.
Dual tropism of HIV-1 in chimpanzee lymphocytes and monocytes.
Dual tuberculosis and HIV epidemic in Chiang Rai, Northern Thailand: The integrated approach.
Dual versus single chamber pacemaker therapy for atrioventricular block and sick sinus syndrome: a systematic review of clinical and cost effectiveness evidence.
Dual-tropic (X4R5) HIV-1 preferentially use CCR5 OR CXCR4 in human lymphoid tissue ex vivo: correlation with CD4+ T cell depletion.
Dual-tropic recombinant chimeric chemokines directed against both M-tropic (R5) and T-Tropic (X4) HIVs.
Dually Inducible Cell Lines to Study the Quantitative CD4 and Co-receptor Dependence of HIV Envelopes.
Duodenal HIV-1 RNA load is increased in both HIV patients with an opportunistic intestinal pathogen or pathogen negative diarrhoea.
Duped by Cries of Duplication.
Duplex surveillance during the first year after infrainguinal autologous vein bypass grafting: what are the costs and clinical outcomes compared to other surveillance programs?
Duplicate reporting of AIDS between two neighbouring countries.
Duplication of a 12 amino acid sequences in HIV-1(MN) p6GAG: similarity to HIV-1(B) type sequences.
Dura lex project.
Durability and reasons for changing antiretroviral regimens in patients on double and highly active antiretroviral therapy.
Durability and tolerability of nevirapine-containing regimens in a cohort of antiretroviral-naive HIV-positive patients.
Durability and tolerability of the triple NRTI Regimen abacavir/zidovudine/lamivudine (ABC/AZT/3TC) based on therapy changes in antiretroviral therapy-naive patients in the Frankfurt HIV Cohort.
Durability of antiretroviral benefit in a university hospital in Brazil.
Durability of antiviral activity of efavirenz (EFV, DMP 266) in combination with indinavir (IDV).
DURABILITY OF EFAVIRENZ COMPARED TO NEVIRAPINE WITH LONG TERM FOLLOW-UP OF AN ANTIRETROVIRAL-NAIVE PATIENT COHORT.
Durability of Gendine Impregnated Silicone and Polyurethane Central Venous Catheters.
Durability of HAART Regimens over Time.
Durability of nelfinavir based HAART.
Durability of quadruple antiretroviral therapy including ritonavir and saquinavir in patients with advanced HIV-1 disease.
Durability of response of efavirenz (sustiva(tm), EFV)-containing regimens: report of the post-control period results of studies with EFV.
Durability of Response of Enfuvirtide through 48 Weeks in the TORO Trials.
Durability of Ritonavir (RTV) plus Saquinavir (SQV) Dual Protease Inhibitor Therapy in HIV Infection: 5-Year Follow-Up.
Durability of salvage therapy with saquinavir sgc (SQV) in combination with ritonavir (RTV) or nelfinavir (NFV) plus delavirdine (DLV), adefovir dipivoxil (ADV), or both-ACTG 359: 48-week final results.
Durability of undetectable viral load (VL) in response to antiretroviral therapy: an assessment of immunologic and virologic parameters.
Durable activity of Ziagen (abacavir, ABC) combined with protease inhibitors (PI) in therapy naive adults.